PHAT

Phathom Pharmaceuticals (PHAT)

About Phathom Pharmaceuticals (PHAT)

Phathom Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel treatments for gastrointestinal diseases. The company was founded by Tadataka Yamada, David Socks, Azmi Nabulsi, Aditya Kohli, and Roger Ulrich on January 9, 2018 and is headquartered in Florham Park, NJ.

Details

Daily high

$7.83

Daily low

$7.39

Price at open

$7.71

52 Week High

$19.71

52 Week Low

$6.06

Market cap

509.4M

Dividend yield

0.00%

Volume

2.5M

Avg. volume

1.0M

P/E ratio

-1.31

Phathom Pharmaceuticals News